The pharmacists' potential to provide targets for interventions to optimize pharmacotherapy in patients with asthma

International Journal of Clinical Pharmacy

Volumn 35, Issue 6, 2013, Pages 1075-1082

  Van Boven, J F M ^a   Hiddink, E G ^a,b   Stuurman Bieze, A G G ^b,c   Schuiling Veninga, C C M ^a   Postma, M J ^a   Vegter, S ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b Stichting Health Base   (Netherlands)

^c 3Apotheek West ^*  (Netherlands)

Author keywords

Asthma; Dispensing records; Interventions; Pharmacist

Indexed keywords

BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CICLESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUTICASONE; FORMOTEROL; IPRATROPIUM BROMIDE; MONTELUKAST; NEDOCROMIL; SALBUTAMOL; SALMETEROL; TERBUTALINE; THEOPHYLLINE; TIOTROPIUM BROMIDE;

ADULT; ARTICLE; ASTHMA; CORTICOSTEROID THERAPY; CROSS-SECTIONAL STUDY; DISEASE EXACERBATION; DRUG THERAPY; DRUG USE; FEMALE; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHARMACIST ATTITUDE; PHARMACY; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; COMMUNITY PHARMACY SERVICES; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PHARMACISTS; PROFESSIONAL ROLE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84892790589     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-013-9829-1     Document Type: Article

References (37)

1. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Updated 2012. http://www.ginasthma. org [Accessed Sept 2012].
2. Geijer RMM, Chavannes N, Muris JWM, Sachs APE, Schermer T, Smeele IJM NHG-Standaard Astma bij volwassenen.Available at: http://nhg.artsennet.nl/ kenniscentrum/k-richtlijnen/k-nhgstandaarden/ Samenvattingskaartje-NHGStandaard/ M27-svk.htm Accessed Oct 2012. HuisartsWet 2007; 50(11):537-551.
3. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the asthma insights and reality in Europe (AIRE) study. Eur Respir J. 2000;16(5):802-7.
4. Soriano JB, Rabe KF, Vermeire PA. Predictors of poor asthma control in European adults. J Asthma. 2003;40(7):803-13.
5. Bereznicki BJ, Peterson GM, Jackson SL, Walters EH, Fitzmaurice KD, Gee PR. Data-mining of medication records to improve asthma management. Med J Aust. 2008;189(1):21-5.
6. Armour CL, Lemay K, Saini B, Reddel HK, Bosnic-Anticevich SZ, Smith LD, et al. Using the community pharmacy to identify patients at risk of poor asthma control and factors which contribute to this poor control. J Asthma. 2011;48(9):914-22.
7. Schatz M, Nakahiro R, Crawford W, Mendoza G, Mosen D, Stibolt TB. Asthma quality-of-care markers using administrative data. Chest. 2005;128(4):1968-73.
8. Winterstein AG, Hartzema AG. Pharmacy-specific quality indicators for asthma therapy. Res Social Adm Pharm. 2005;1(3): 430-45.
9. Klomp H, Lawson JA, Cockcroft DW, Chan BT, Cascagnette P, Gander L, et al. Examining asthma quality of care using a population-based approach. CMAJ. 2008;178(8):1013-21.
10. Stuurman-Bieze AG, van den Berg PB, Tromp TF, de Jong-van den Berg LT. Computer-assisted medication review for asthmatic patients as a basis for intervention. Constructing and validating an algorithmic computer instrument in pharmacy practice. Pharm World Sci. 2004;26(5):289-96.
11. Schirm E, Monster TB, de Vries R, van den Berg PB, de Jong-van den Berg LT, Tobi H. How to estimate the population that is covered by community pharmacies? An evaluation of two methods using drug utilisation information. Pharmacoepidemiol Drug Saf. 2004;13(3):173-9.
12. van Boven JF, de Jong-van den Berg LT, Vegter S. Inhaled corticosteroids and the occurrence of oral candidiasis: a prescription sequence symmetry analysis. Drug Saf. 2013;36(4):231-6.
13. WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment. Oslo, 2012. Available at http://www.whocc.no/atcddd Accessed Oct 2012.
14. Pont LG, van der Werf GT, Denig P, Haaijer-Ruskamp FM. Identifying general practice patients diagnosed with asthma and their exacerbation episodes from prescribing data. Eur J Clin Pharmacol. 2002;57(11):819-25.
15. Osborne ML, Vollmer WM, Johnson RE, Buist AS. Use of an automated prescription database to identify individuals with asthma. J Clin Epidemiol. 1995;48(11):1393-7.
16. Wong MD,Manley RT, Stettin G, Chen W, Salmun LM. Intervention to reduce unnecessary dispensing of short-acting {beta}-agonists in patients with asthma. Ann Pharmacother. 2010;44(4):623-9.
17. Gaist D, Hallas J, Hansen NC, Gram LF. Are young adults with asthma treated sufficiently with inhaled steroids? A populationbased study of prescription data from 1991 and 1994. Br J Clin Pharmacol. 1996;41(4):285-9.
18. Davidsen JR, Hallas J, Sondergaard J, Christensen RD, Siersted HC, Hansen MP, et al. Association between prescribing patterns of anti-asthmatic drugs and clinically uncontrolled asthma: a cross-sectional study. Pulm Pharmacol Ther. 2011;24(6):647-53.
19. Salpeter S, Ormiston T, Salpeter E. Cardioselective beta-blockers for reversible airway disease. Cochrane Database Syst Rev 2002;(4)(4):CD002992.
20. Brooks TW, Creekmore FM, Young DC, Asche CV, Oberg B, Samuelson WM. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers. Pharmacotherapy. 2007; 27(5):684-90.
21. Veninga CC, Denig P, Pont LG, Haaijer-Ruskamp FM. Comparison of indicators assessing the quality of drug prescribing for asthma. Health Serv Res. 2001;36(1 Pt 1):143-61.
22. Rodrigo GJ, Moral VP, Marcos LG, Castro-Rodriguez JA. Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review. Pulm Pharmacol Ther. 2009;22(1):9-19.
23. van der Palen J, Klein JJ, van Herwaarden CL, Zielhuis GA, Seydel ER. Multiple inhalers confuse asthma patients. Eur Respir J. 1999;14(5):1034-7.
24. Neville RG, Hoskins G, Smith B, Clark RA. How general practitioners manage acute asthma attacks. Thorax. 1997;52(2):153-6.
25. Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM. SMART Study Group. The salmeterol multicenter asthma research trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest. 2006;129(1): 15-26.
26. Rider NL, Craig TJ. A safety review of long-acting beta2-agonists in patients with asthma. J Am Osteopath Assoc. 2006;106(9): 562-7.
27. DiSantostefano RL, Davis KJ. Prescription patterns in asthma patients initiating salmeterol in UK general practice: a retrospective cohort study using the general practice research database (GPRD). Drug Saf. 2011;34(6):511-20.
28. Hammerlein A, Muller U, Schulz M. Pharmacist-led intervention study to improve inhalation technique in asthma and COPD patients. J Eval Clin Pract. 2011;17(1):61-70.
29. De Gier JJ. Commentaren Medicatiebewaking. ISBN 978-90-74027-00-7. Houten: Health Base; 2012-2013.
30. Self T, Soberman JE, Bubla JM, Chafin CC. Cardioselective betablockers in patients with asthma and concomitant heart failure or history of myocardial infarction: when do benefits outweigh risks? J Asthma Dec. 2003;40(8):839-45.
31. Chafin CC, Soberman JE, Demirkan K, Self T. Beta-blockers after myocardial infarction: do benefits ever outweigh risks in asthma? Cardiology. 1999;92(2):99-105.
32. Bereznicki BJ, Peterson GM, Jackson SL, Walters H, Fitzmaurice K, Gee P. Pharmacist-initiated general practitioner referral of patients with suboptimal asthma management. Pharm World Sci. 2008;30(6):869-75.
33. Stuurman-Bieze AG, de Boer WO, Kokenberg ME, Hugtenburg JG, de Jong-van den Berg LT, Tromp TF. Complex pharmaceutical care intervention in pulmonary care: part A. The process and pharmacists' professional satisfaction. Pharm World Sci. 2005;27(5):376-84.
34. de Vries TW, van den Berg PB, Duiverman EJ, de Jong-van den Berg LT. Effect of a minimal pharmacy intervention on improvement of adherence to asthma guidelines. Arch Dis Child. 2010;95(4):302-4.
35. Armour C, Bosnic-Anticevich S, Brillant M, Burton D, Emmerton L, Krass I, et al. Pharmacy asthma care program (PACP) improves outcomes for patients in the community. Thorax. 2007;62(6):496-502.
36. Stuurman-Bieze AG, Hiddink EG, Van Boven JF, Vegter S. Proactive pharmaceutical care interventions improve patients' adherence to lipid lowering medication. Annals of Pharmacotherapy 2013. In press.
37. Van Boven JFM, Hiddink EG, Stuurman-Bieze AGG, Postma MJ, Vegter S. Structured medication surveillance for improving adherence to bisphosphonate therapy offers perspectives for costeffective pharmaceutical care. Pharm Weekbl Wet Platf. 2011; 5(8):160-6.